Most of us want longevity, especially if our quality of life remains generally solid as we age. The combination of length and quality of life is sometimes called “healthspan.” How do we get the maximum health span? Easier said than done. Not all of the obstacles are biological either. Unfortunately, accompanying all the legitimate research […]
The post Weekly reads: Topol on longevity biz, Peter Marks out at FDA, timeless NIH grant advice appeared first on The Niche.